Circulate Health, a leader in precision Therapeutic Plasma Exchange (TPE) technologies and microplastics technologies, announces a strategic investment from Scrum Ventures, a global early-stage venture capital firm known for its strong focus on sports, human performance, and next-generation health technologies.

Circulate Health 是精准治疗性血浆置换 (TPE) 技术和微塑料技术的领导者，宣布获得全球早期风险投资公司 Scrum Ventures 的战略投资，该公司以其对体育、人类表现和下一代健康技术的高度关注而闻名。

The seven-figure investment will accelerate Circulate's ongoing growth..

七位数的投资将加速Circulate的持续增长。